The American business community is determined not to comment on the crackdown in Xinjiang — atrocities the U.S. government has deemed a genocide. But how long can their silence last?
Listen to SupChina editor-at-large and Sinica podcast host Kaiser Kuo read this article.
About halfway through the four-hour confirmation hearing for Antony Blinken, President-elect Joe Biden’s nominee for Secretary of State, Senator Lindsey Graham let out a sigh of relief. Earlier that day — the last full day of Donald Trump’s presidency — Secretary of State Mike Pompeo had called China’s actions against ethnic minorities in the Xinjiang region a genocide. It was a significant announcement — this is only the sixth time in history the U.S. has determined a genocide is taking place — and Senator Graham, an ally of the Trump administration, was testing Blinken on whether or not he agreed with the designation.
“That would be my judgment as well,” Blinken said. “You do agree?” Graham asked again. “Yes,” said Blinken, unflinchingly.
“We’re off to a good start here,” Graham then said, laughing. Later on in the hearings, Bl
Subscribe, register or login to read the rest. Registered users can access a limited amount of content for free.
Subscribers get full access to:
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from David Barboza, Pulitzer Prize-winning former Shanghai correspondent for The New York Times.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
As the Chinese ridehailing app prepares for a giant IPO in New York, a look back at how it rose to global prominence — and why one of its biggest obstacles going forward could take place on its home turf.
Thanks to impressive e-commerce operations and social media marketing, Shein, a little known Chinese brand, is giving global giants a run for their money.
The global health expert talks about China's handling of Covid-19, vaccines, and why — when it comes to policy implementation — China is remarkably resilient but also fundamentally flawed.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy
